Close Menu

Stephen Colbert's April 15 interview with Kevin Noonan, makes a pretty good case for gene patenting, says Patent Docs' Donald Zuhn, who works with Noonan. Noonan has been defending Myriad's right to the breast cancer gene patent that was ruled invalid in March.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.